重大公告
Announcement of BOD’s resolution to lift the non-competition restrictions for managerial officers
1.Date of the board of directors resolution:2024/03/11 2.Name and title of the managerial officer with permission to engage in competitive conduct: Heidi Wang/ CEO Ming-Tain …
Announcement of 2023 Consolidated Financial Statements were approved by the Board of Directors
1.Date of the board of directors submitted or approved:2024/03/11 2.Date of the audit committee approved:2024/03/08 3.Start and end dates of financial reports or unaudited financial …
The Company’s Board of Directors resolved to convene the 2024 Annual General Shareholders’ Meeting
1.Date of the board of directors resolution:2024/03/11 2.General shareholders’ meeting date:2024/06/17 3.General shareholders’ meeting location: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, …
Announcement of not Distributing Dividends in 2023
1.Date of the board of directors resolution:2024/03/11 2.Year or quarter which dividends belong to :2023 3.Period which dividends belong to:2023/1/1 to 2023/12/31 4.Appropriations of earnings …
OBI announces the termination of OBI-3424-001 trial while continuing the collaboration of OBI-3424 with partners
1.Date of occurrence of the event:2024/03/11 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios: …